Accepting new patients

Trudy C. Wu, MD

  • Radiation Oncology
Westwood Radiation Oncology | 200 Medical Plaza, Suite B265, Los Angeles, CA 90095

About

Dr. Trudy Wu is an Assistant Professor with a focus on the treatment of gastrointestinal malignancies. She earned her Bachelor of Science in Biology from The Ohio State University. Later, she graduated Magna Cum Laude, receiving the prestigious Landacre Research Honor, from The Ohio State College of Medicine.

During her residency at UCLA, Dr. Wu made significant contributions to research projects, which have been featured in numerous peer-reviewed journals. Notably, she first authored over fifteen publications, including manuscripts in esteemed journals like, JAMA Oncology and the International Journal of Radiation Oncology, Biology, Physics. Her clinical and research expertise is centered on the treatment of gastrointestinal malignancies. As an advocate for medical education and early-career development, Dr. Wu mentors and educates through various platforms, including the At The Beam podcast, which she created to improve oncology education among medical professionals. 

In 2024, Dr. Wu was honored as the ARRO Resident Educator of the Year, recognizing her influence on medical education nationwide. She is an active member of several professional societies, including the American Radium Society, where she serves as Chair of the Radiation Oncology Career Knowledge for Early Career Trainees (ROCKET) Task Force and is a member of the Executive Committee.

Driven by a personal connection to cancer through her father’s diagnosis, Dr. Wu is dedicated to enhancing outcomes for patients with cholangiocarcinoma and has been a Research Advocate for The Cholangiocarcinoma Foundation for over five years. Beyond her professional endeavors, Dr. Wu is an accomplished marathon runner, finishing 28th in her age group at the Los Angeles Marathon. She is also a former figure skater and has passed both her senior free skate and moves in the field with the US Figure Skating Association.

Languages

English

Education

Residency

Radiation Oncology, University of California, Los Angeles, Department of Radiation Oncology, 2024

Internship

Transitional Year, Mount Carmel Health System, 2020

Degree

MD, Ohio State University College of Medicine, 2019

Recognitions

  •  Association of Residents in Radiation Oncology (ARRO), Resident Educator of the Year, 2024
  • Radiological Society of North America (RSNA), Roentgen Resident Research Award, 2024
  • American College of Radiation Oncology (ACRO), Luther Brady Educational Grant Recipient, 2022
  • See More

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Videos

Profile
Meet Trudy C. Wu, MD

Research

Interests

  • Gastrointestinal Malignancies
  • MR-guided radiotherapy
  • Adaptive Radiotherapy 

Publications

  1. Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee P. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Mar 1;10(3):352-359. doi: 10.1001/jamaoncol.2023.6033. PMID: 38206614
  2. Wu TC, Farrell MJ, Karimi-Mostowfi N, Chaballout BS, Akingbemi WO, Grogan T, Raldow AC “Evaluating the Impact of Race and Ethnicity on Health-Related Quality of Life Disparities in Patients with Esophageal Cancer: A SEER-MHOS National Database Study” Cancer Epidemiol Biomarkers Prev. 2023 Nov 28. doi: 10.1158/1055-9965.EPI-23-0789. Epub ahead of print. PMID: 38015776
  3. Wu TC, Deng J, Chu F, Sadeghi S, Finn R, Agopian VG, Lee P, Raldow AC A Single Center Experience Using Stereotactic Body Radiation Therapy (SBRT) on Orthotopic Liver Transplant Protocol for Unresectable CholangiocarcinomaHPB (Oxford). 2023 Dec 10:S1365-182X(23)02011-7. doi: 10.1016/j.hpb.2023.12.004. Epub ahead of print. PMID: 38142182
  4. Wu TC, Smith LM, Woolf D, Faivre-Finn C, Lee P. Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non-Small-Cell Lung Cancer: Who are the Optimal Candidates? Semin Radiat Oncol. 2024 Jan;34(1):56-63. doi: 10.1016/j.semradonc.2023.10.007. PMID: 38105094.
  5. Wu TC, Smith CP, Li JS, Burton J, Jackson NJ, Tao R, Ludmir EB, Raldow AC. A Systematic Review and Meta-analysis of Pathologic Complete Response Rates for Patients with Unresectable Cholangiocarcinoma treated on Orthotopic Liver Transplant Protocols. J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27511. Epub ahead of print. PMID: 37986552
  6. Wu TC*, No HJ*, Rahimy E, Kishan AU, Steinberg ML, Raldow AC, Beadle BM. Performance Analysis of a Radiation Oncology Educational Podcast. J Am Coll Radiol. 2023 Jul 27:S1546-1440(23)00533-1. doi: 10.1016/j.jacr.2023.06.026. Epub ahead of print. PMID: 37516159.
  7. Wu TC, Stube A, Felix C, Oseguera D, Romero T, Goldman J, Garon EB, Lee JM, Glaspy J, Lisberg AE, Rusthoven CG, Camidge DR, Siva S, Solomon B, Lee A, Tenn SE, Shaverdian N, Steinberg ML, Raldow AC, Lee P. Safety and Efficacy Results from iSABR, a Phase I Study of Stereotactic Ablative Radiotherapy (SABR) in Combination with Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2023 Apr 4:S0360-3016(23)00325-5. doi: 10.1016/j.ijrobp.2023.03.069. Epub ahead of print. PMID: 37023987.
  8. Wu TC, McCloskey SA. Established and new horizons in radiotherapy for breast cancer. Ther Adv Med Oncol. 2023 Mar 18;15:17588359231161415. doi: 10.1177/17588359231161415. PMID: 36950271
  9. Wu TC, Yoon SM, Cao M, Raldow AC, Xiang M. Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT). Clin Transl Radiat Oncol. 2023 Feb 22;40:100603. doi: 10.1016/j.ctro.2023.100603. PMID: 36896266
  10. Wu TC, Sanford NN, Anand S, Chu FI, Wo JY, Raldow AC. Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons. Clin Colorectal Cancer. 2022 Dec;21(4):309-314. doi: 10.1016/j.clcc.2022.06.001. Epub 2022 Sep 16. PMID: 36216758

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  •  Association of Residents in Radiation Oncology (ARRO), Resident Educator of the Year, 2024
  • Radiological Society of North America (RSNA), Roentgen Resident Research Award, 2024
  • American College of Radiation Oncology (ACRO), Luther Brady Educational Grant Recipient, 2022
  • Mount Carmel Health System, Foundation President’s Excellence Fund, 2020